|
![spacer](https://webarchive.library.unt.edu/eot2008/20090115030233im_/http://wwwn.cdc.gov/i/s.gif) |
![spacer](https://webarchive.library.unt.edu/eot2008/20090115030233im_/http://wwwn.cdc.gov/i/s.gif) |
![spacer](https://webarchive.library.unt.edu/eot2008/20090115030233im_/http://wwwn.cdc.gov/i/s.gif) |
![spacer](https://webarchive.library.unt.edu/eot2008/20090115030233im_/http://wwwn.cdc.gov/i/s.gif) |
![Communication: The Key to Appropriate Genetic Test Referral, Result Reporting and Interpretation](https://webarchive.library.unt.edu/eot2008/20090115030233im_/http://wwwn.cdc.gov/dls/images/comm052003.jpg)
Mt. Sinai School of Medicine
May 2-3, 2003
Co-hosted by:
Mt. Sinai School of Medicine and the
Centers for Disease Control and Prevention
|
Meeting Objective:
The conference was convened to explore communication issues among professionals
relevant to the ordering, reporting, and interpretation of genetic tests that
impacts health care decision-making. Cystic fibrosis DNA-based testing served
as a model for discussion.
Meeting Outcomes:
-
Problems and challenges were identified in the process of ordering, reporting,
and using genetic tests. There is a lack of quantifiable data relating these to
patient outcomes and other costs associated with the testing process.
-
Opportunities were identified for improving practices and professional
competencies. General and specific strategies to address (resolve) current
problems (bridging communication gaps) were provided.
-
In considering next steps, the ordering and reporting of genetic tests needs
to be considered as a process with internal and external quality control and
provisions for assuring professional competencies.
-
The multidisciplinary format of this conference and resulting recommendations
strongly support the need for enhanced interdisciplinary interactions toward
assuring the safe and effective use of genetic tests.
Follow-up:
|
This page last reviewed: 8/19/2004
|
|